Abstract
Tremendous progress has been made in the diagnosis, prevention, and treatment of pediatric stroke. With a complete investigation, stroke etiology can be determined in most children, and multiple factors are commonly identified. Stroke can be prevented in some children and treated in others. Children at risk for recurrent strokes can be treated effectively. The prognosis after pediatric stroke is usually good, but today we can identify and initiate treatment in selected patients at risk for long-term problems. This article reviews recent advances in the identification, prevention, treatment, and outcome in pediatric ischemic stroke.
Similar content being viewed by others
References and Recommended Reading
Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250–255.
deVeber G, Andrew M: Canadian pediatric ischemic stroke registry. Analysis I. Pediatr Res 1994, 35:379A.
Gunther G, Junker R, Strater R, et al.: Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke 2000, 31:2437–2441. Multicenter, prospective study of 91 newborns with symptomatic ischemic stroke. One or more prothrombotic risk factors were identified in the 68.1% of patients, but in only 24.2% of control patients. Additional triggering factors were present in 54%.
deVeber G, Andrew M: Canadian Pediatric Ischemic Stroke Study. Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 345:417–423. Multicenter, prospective study of 160 children with sinovenous thrombosis. Of the 160 children, 43% were neonates. Risk factors (head/neck disorders, prothrombotic states, systemic illness) were identified in more than 95% of patients. Only 8% of the children died, but 38% had residual neurologic deficits.
Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288–294.
DeBaun MR, Schatz J, Siegel MJ, et al.: Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 1998, 50:1678–1682.
Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography [comment]. New Engl J Med 1998, 339:5–11.
Adams RJ: Stroke prevention and treatment in sickle cell disease. Arch Neurol 2001, 58:565–568.
Anonymous: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581–1587.
Grotta J: Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients. N Engl J Med 1997, 337:1310–1313.
Kwiatkowski TG, Libman RB, Frankel M, et al.: Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999, 340:1781–1787.
Thirumalai SS, Shubin RA: Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000, 15:558.
Carlson MD, Leber S, Deveikis J, Silverstein FS: Successful use of rt-PA in pediatric stroke. Neurology 2001, 57:157–158.
Clancy RR, McGaurn SA, Goin JE, et al.: Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001, 108:61–70. The first, and to date the only, blinded, placebo-controlled neuroprotection trial in children. The authors demonstrated a significant benefit of allopurinol preoperatively to high-risk infants undergoing hypoplastic left heart surgery.
Wagner CL, Eicher DJ, Katikaneni LD, et al.: The use of hypothermia: a role in the treatment of neonatal asphyxia? Pediatr Neurol 1999, 21:429–443.
Huh PW, Belayev L, Zhao W, et al.: Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia. J Neurosurg 2000, 92:91–99.
Azzopardi D, Robertson NJ, Cowan FM, et al.: Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 2000, 106:684–694.
Battin MR, Dezoete JA, Gunn TR, et al.: Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics 2001, 107:480–484.
Fullerton HJ, Johnston SC, and Smith WS: Arterial dissection and stroke in children. Neurology 2001, 57:1155–1160.
Cardo E, Vilaseca MA, Campistol J, et al.: Evaluation of hyperhomocysteinaemia in children with stroke. Eur J Paediatr Neurol 1999, 3:113–117.
Prengler M, Stuart N, Krywawych S, et al.: Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol 2001, 43:220–225. In this study, 19% (n=22) of children (vs 12% of control patients) with ischemic stroke or transient ischemic attack (n=118) were homozygous for the thermolabile methyletrahydrofolate reductase allele and had increased plasma homocysteine concentration. These patients were more likely to have recurrent stroke. The authors discuss treatment options.
deVeber GA, MacGregor D, Curtis R, Mayank S: Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000, 15:316–324. One of the few papers to examine long-term neurologic outcome after pediatric stroke. Almost two thirds of 161 children with arterial ischemic stroke or sinovenous thrombosis had residual neurologic deficits.
Sreenan CR, Bhargava, Robertson CM: Cerebral infarction in the term newborn: clinical presentation and long-term outcome. J Pediatr 2000, 137:351–355.
Mercuri E, Cowan F, Gupte G, et al.: Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001, 107:1400–1404.
Mercuri E, Rutherford M, Cowan F, et al.: Early prognostic indicators of outcome in infants with neonatal cerebral infarction: a clinical, electroencephalogram, and magnetic resonance imaging study. Pediatrics 1999, 103:39–46.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Younkin, D.P. Diagnosis and treatment of ischemic pediatric stroke. Curr Neurol Neurosci Rep 2, 18–24 (2002). https://doi.org/10.1007/s11910-002-0048-8
Issue Date:
DOI: https://doi.org/10.1007/s11910-002-0048-8